Ancestry launches consumer genetics tests for health
The consumer genetics company Ancestry is no longer just about, well, ancestry.
The company today is rolling genetic health tests for the first time, putting it in direct competition with 23andMe. But Ancestry has chosen a very different strategy than its rival — deciding that the tests will be ordered by a physician. That means that it will be regulated not by the FDA but by the Centers for Medicare and Medicaid Services under the rules for physician-ordered diagnostic tests.
“Ancestry has largely escaped much of the controversy that has dogged consumer genomics,” Dr. Robert Green of Brigham and Women’s Hospital told STAT's Matthew Herper. “Now by specifically by taking their brand into health care, they are inviting the controversy about completeness, about accuracy, about communication, about potential medical miscommunication, about false reassurance."
Read more.
The company today is rolling genetic health tests for the first time, putting it in direct competition with 23andMe. But Ancestry has chosen a very different strategy than its rival — deciding that the tests will be ordered by a physician. That means that it will be regulated not by the FDA but by the Centers for Medicare and Medicaid Services under the rules for physician-ordered diagnostic tests.
“Ancestry has largely escaped much of the controversy that has dogged consumer genomics,” Dr. Robert Green of Brigham and Women’s Hospital told STAT's Matthew Herper. “Now by specifically by taking their brand into health care, they are inviting the controversy about completeness, about accuracy, about communication, about potential medical miscommunication, about false reassurance."
Read more.
.png)
No hay comentarios:
Publicar un comentario